Skip to main content

Hip Replacement in Osteoarthritis Patients

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Frontera Therapeutics
Frontera TherapeuticsChina - Suzhou
1 program
Prehabilitation in Older People Undergoing Total Hip ReplacementN/A1 trial
Active Trials
NCT07048080Not Yet Recruiting70Est. Mar 2029

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
2029
Frontera TherapeuticsPrehabilitation in Older People Undergoing Total Hip Replacement

Clinical Trials (1)

Total enrollment: 70 patients across 1 trials

NCT07048080Frontera TherapeuticsPrehabilitation in Older People Undergoing Total Hip Replacement

Prehabilitation in Older People Undergoing Total Hip Replacement

Start: Aug 2025Est. completion: Mar 202970 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.